
SPAC
GNQ Insilico's De-SPAC: What Investors Need to Know
GNQ Insilico is a TechBio precision-medicine company combining genomics, AI, and quantum computing, and it plans to go public by merging with IB Acquisition Corp. The deal is set up for a Q3 2026 close, but the real story is whether redemptions, dilution, and financing leave enough cash for the platform to execute.
Jul 28, 20266 MIN
